|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
102.77(B) |
Last
Volume: |
8,713,116 |
Avg
Vol: |
8,469,733 |
52
Week Range: |
$48.64 - $73.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
96,581 |
377,614 |
901,711 |
1,862,313 |
Total Sell Value |
$6,534,949 |
$22,111,166 |
$49,794,655 |
$91,194,728 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
10 |
20 |
37 |
70 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2024-02-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
550 |
4,894 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2024-02-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
184,354 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,722) |
28,011 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
22,666 |
37,733 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,983) |
57,678 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
65,661 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,472) |
47,336 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
52,808 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,450) |
190,354 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
33,332 |
206,804 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,579) |
26,197 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
37,776 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(65,047) |
1,636,356 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
146,666 |
1,701,403 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,160) |
71,094 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
26,666 |
83,254 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,262) |
262,142 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
36,666 |
278,404 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2024-01-12 |
4 |
AS |
$60.00 |
$699,600 |
D/D |
(11,660) |
173,472 |
|
22% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-01-09 |
4 |
AS |
$59.25 |
$898,941 |
D/D |
(15,172) |
56,588 |
|
24% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-01-09 |
4 |
OE |
$16.31 |
$247,455 |
D/D |
15,172 |
71,760 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-01-04 |
4 |
AS |
$58.40 |
$876,002 |
D/D |
(15,000) |
56,588 |
|
26% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-01-04 |
4 |
OE |
$16.31 |
$244,650 |
D/D |
15,000 |
71,588 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-01-03 |
4 |
AS |
$57.82 |
$689,862 |
D/D |
(11,931) |
56,588 |
|
27% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-01-01 |
4 |
D |
$57.81 |
$318,417 |
D/D |
(5,508) |
68,519 |
|
- |
|
2518 Records found
|
|
Page 5 of 101 |
|
|